Respiratory Devices Are Becoming More Popular As The Global Population Ages And More People Become Vulnerable To Chronic Diseases
![]() |
Respiratory Devices |
Respiratory Devices are a wide variety of devices used
to diagnose, treat and monitor respiratory diseases. These devices include
breathing apparatus for resuscitation and long-term artificial respiration.
Some of the devices commonly used in the respiratory device market are oxygen
therapy machines, ventilation machines, inhaled aerosol medication dispensers
and ventilators.
Respiratory
Devices include CPAP machines, invasive ventilators, oxygen
concentrators, nebulizers, and anesthesia systems. Increasing numbers of people
worldwide are suffering from chronic conditions that require regular care and
treatment. Thus, regulatory agencies are stepping in to help ensure that these
lifesaving devices are available when they are needed.
While some respiratory devices are considered medically
necessary, others are not. For example, vaporizers and incentive spirometers
are not covered by most insurances. However, they have been shown to be
beneficial in controlled studies. In addition, nontraditional respirator user
populations such as workers outside formal respiratory protection programs may
need to wear respiratory protection in order to stay safe.
FDA has issued guidance to expand the availability of Respiratory Devices. The guidance
addresses both invasive and noninvasive ventilators, anesthesia gas machines,
and accessories. It provides information on how to design and test these
products for medical use.
One of the most important things about Respiratory Devices is that they need to be extremely accurate. The
devices are designed to detect minute flow rates around the zero point of
respiratory flow. With this feature, the device can preset a predetermined
amount of overpressure if the patient's inhalation phase is detected early.
Typically, the devices are not intended to be used for more than one person.
Respiratory Devices are becoming more popular as the
global population ages and more people become vulnerable to chronic diseases.
The influx of elderly patients has led to a shortage of ventilators,
nebulizers, oxygen concentrators, and anesthesia systems in hospitals
worldwide. Due to this, device manufacturers are racing to meet this demand. In
March 2021, PARI Pharma GmbH, authorized LAMIRA Nebulizer System for delivery
of drug product ARIKAYCE of Insmed in Japan.
Comments
Post a Comment